These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19216007)

  • 21. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
    Hill TA; Gordon CP; McGeachie AB; Venn-Brown B; Odell LR; Chau N; Quan A; Mariana A; Sakoff JA; Chircop M; Robinson PJ; McCluskey A
    J Med Chem; 2009 Jun; 52(12):3762-73. PubMed ID: 19459681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional structure-activity relationship study of belactosin A and its stereo- and regioisomers: development of potent proteasome inhibitors by a stereochemical diversity-oriented strategy.
    Yoshida K; Yamaguchi K; Mizuno A; Unno Y; Asai A; Sone T; Yokosawa H; Matsuda A; Arisawa M; Shuto S
    Org Biomol Chem; 2009 May; 7(9):1868-77. PubMed ID: 19590782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.
    Ni S; Yuan Y; Huang J; Mao X; Lv M; Zhu J; Shen X; Pei J; Lai L; Jiang H; Li J
    J Med Chem; 2009 Sep; 52(17):5295-8. PubMed ID: 19691347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.
    Wang X; Lin J; Chen Y; Zhong W; Zhao G; Liu H; Li S; Wang L; Li S
    Bioorg Med Chem; 2009 Mar; 17(5):1898-904. PubMed ID: 19223187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Versatile synthesis of oligodeoxyribonucleotide-oligospermine conjugates.
    Voirin E; Behr JP; Kotera M
    Nat Protoc; 2007; 2(6):1360-7. PubMed ID: 17545974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
    Tang H; Wei YB; Zhang C; Ning FX; Qiao W; Huang SL; Ma L; Huang ZS; Gu LQ
    Eur J Med Chem; 2009 Jun; 44(6):2523-32. PubMed ID: 19243862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthesis-driven structure revision of berkelic acid methyl ester.
    Buchgraber P; Snaddon TN; Wirtz C; Mynott R; Goddard R; Fürstner A
    Angew Chem Int Ed Engl; 2008; 47(44):8450-4. PubMed ID: 18816540
    [No Abstract]   [Full Text] [Related]  

  • 28. Stereoselective HDAC inhibition from cysteine-derived zinc-binding groups.
    Butler KV; He R; McLaughlin K; Vistoli G; Langley B; Kozikowski AP
    ChemMedChem; 2009 Aug; 4(8):1292-301. PubMed ID: 19551801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors.
    Mizutani T; Ishikawa S; Nagase T; Takahashi H; Fujimura T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    J Med Chem; 2009 Nov; 52(22):7289-300. PubMed ID: 19883081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting the pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors.
    La Motta C; Sartini S; Mugnaini L; Salerno S; Simorini F; Taliani S; Marini AM; Da Settimo F; Lavecchia A; Novellino E; Antonioli L; Fornai M; Blandizzi C; Del Tacca M
    J Med Chem; 2009 Mar; 52(6):1681-92. PubMed ID: 19226143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of a novel 3-sulfonyl-8-azabicyclo[3.2.1]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.
    Nagase T; Takahashi T; Sasaki T; Nagumo A; Shimamura K; Miyamoto Y; Kitazawa H; Kanesaka M; Yoshimoto R; Aragane K; Tokita S; Sato N
    J Med Chem; 2009 Jul; 52(14):4111-4. PubMed ID: 19522500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding CYP2D6 interactions.
    de Groot MJ; Wakenhut F; Whitlock G; Hyland R
    Drug Discov Today; 2009 Oct; 14(19-20):964-72. PubMed ID: 19638317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of radiolabeled 9-cis- and all-trans-retinoids.
    Tadikonda PK; DeLuca HF
    Methods Enzymol; 1997; 282():108-17. PubMed ID: 9330281
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylases.
    Grolla AA; Podestà V; Chini MG; Di Micco S; Vallario A; Genazzani AA; Canonico PL; Bifulco G; Tron GC; Sorba G; Pirali T
    J Med Chem; 2009 May; 52(9):2776-85. PubMed ID: 19344175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of enediyne-peptide conjugates and their inhibiting activity against chymotrypsin.
    Dutta S; Basak A; Dasgupta S
    Bioorg Med Chem; 2009 Jun; 17(11):3900-8. PubMed ID: 19428261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
    Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
    Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design of an organometallic glutathione transferase inhibitor.
    Ang WH; Parker LJ; De Luca A; Juillerat-Jeanneret L; Morton CJ; Lo Bello M; Parker MW; Dyson PJ
    Angew Chem Int Ed Engl; 2009; 48(21):3854-7. PubMed ID: 19396894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.
    Uto Y; Ogata T; Harada J; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Abe M; Kurikawa N; Kawamura S; Yamato M; Osumi J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4151-8. PubMed ID: 19540759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.